EGFR and non-small cell lung carcinoma: However, some NSCLC patients without EGFR mutation still respond to TKIs [6-11], which suggesting that there may be mechanism(s) other than the EGFR pathway by which TKIs can cause apoptosis in NSCLC cells without EGFR mutation.